Publications

For all our publications, please see PubMed.

IBS

  • Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms (Scientific Reports, 2019)
    (Botschuijver S, van Diest SA, van Thiel IAM, Saia RS, Strik AS, Yu Z, Maria-Ferreira D, Welting O, Keszthelyi D, Jennings G, Heinsbroek SEM, Elferink RPO, Schuren FHJ, de Jonge WJ, van den Wijngaard RM)
    Click here to visit this publication.

IBD

  • A distinct epigenetic profile distinguishes stenotic from non-inflamed fibroblasts in the ileal mucosa of Crohn's disease patients (PLoS One, 2018)
    (Li Yim AYF, de Bruyn JR, Duijvis NW, Sharp C, Ferrero E, de Jonge WJ, Wildenberg ME, Mannens MMAM, Buskens CJ, D'Haens GR, Henneman P, Te Velde AA)
    Click here to visit this publication.
  • A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function (Inflammatory Bowel Diseases, 2019)
    (De Vries LCS, Duarte JM, De Krijger M, Welting O, Van Hamersveld PHP, Van Leeuwen-Hilbers FWM, Moerland PD, Jongejan A, D'Haens GR, De Jonge WJ, Wildenberg ME)
    Click here to visit this publication.

Neuro-immunity

  • Acetylcholine-producing T cells augment innate immune-driven colitis but are redundant in T cell-driven colitis (Gastrointestinal and liver physiology, 2019)
    (Willemze RA1, Brinkman DJ1,2, Welting O1, van Hamersveld PHP1, Verseijden C1, Luyer MD2, Wildenberg ME1, Seppen J1, de Jonge WJ)
    Click here to visit this publication.
  • Neuroimmune Interactions in the Gut and Their Significance for Intestinal Immunity (Cells, 2019)
    (Brinkman DJ, Ten Hove AS, Vervoordeldonk MJ, Luyer MD, de Jonge WJ)
    Click here to visit this publication.